Nicholas Fischer retweetledi

Not sure why this isn’t bigger news.
The NIH SBIR/STTR programs lapsed on October 1, 2025. No new grant solicitations can be authorized. The tremendous value these funding sources bring to our nation’s economy isn’t contested, but there’s an impasse about how the program should be structured.
A year extension was authorized with bipartisan support by the House, but it’s stalled in the Senate. #HR5100
nsbaadvocate.org/post/news-sbir…
English


















